Cryoport (CYRX) said Wednesday that it has opened a new supply chain facility in Louvres, France.

The facility provides end-to-end, temperature-controlled logistics for biopharma, including cell and gene therapies, biologics, animal health and reproductive medicine, the company said.

The facility also plans to provide BioServices, biostorage, QP drug management and importer of record services over the coming months, it said.

The project received partial funding under a grant from the Ile-de-France region to support initial operations, Cryoport said.

The facility will be immediately operational and becomes the third global supply chain center campus in Cryoport's network.